RT @BoggildLab: 5/11 Related to Ruwandi's thesis work was her validation of a commercial susceptibility platform to evaluate ampho B & fluc…
RT @BoggildLab: 5/11 Related to Ruwandi's thesis work was her validation of a commercial susceptibility platform to evaluate ampho B & fluc…
RT @BoggildLab: 5/11 Related to Ruwandi's thesis work was her validation of a commercial susceptibility platform to evaluate ampho B & fluc…
RT @BoggildLab: 5/11 Related to Ruwandi's thesis work was her validation of a commercial susceptibility platform to evaluate ampho B & fluc…
5/11 Related to Ruwandi's thesis work was her validation of a commercial susceptibility platform to evaluate ampho B & fluconazole susceptibility in clinical & reference strains of Leishmania. See @BioMedCentral journal BMC ID: https://t.co/Jg8XIJK
RT @ruwandik: ❗️New Publication Alert from the @BoggildLab❗️A piece I was thrilled to lead: #Susceptibility testing of #Leishmania spp. aga…
RT @ruwandik: ❗️New Publication Alert from the @BoggildLab❗️A piece I was thrilled to lead: #Susceptibility testing of #Leishmania spp. aga…
RT @ruwandik: ❗️New Publication Alert from the @BoggildLab❗️A piece I was thrilled to lead: #Susceptibility testing of #Leishmania spp. aga…
RT @BoggildLab: New paper out today by outstanding @BoggildLab team @ruwandik @PriyankaChalla7 and @rachellau25 on ampho and fluc S…
RT @ruwandik: ❗️New Publication Alert from the @BoggildLab❗️A piece I was thrilled to lead: #Susceptibility testing of #Leishmania spp. aga…
RT @BoggildLab: New paper out today by outstanding @BoggildLab team @ruwandik @PriyankaChalla7 and @rachellau25 on ampho and fluc S…
RT @BoggildLab: New paper out today by outstanding @BoggildLab team @ruwandik @PriyankaChalla7 and @rachellau25 on ampho and fluc S…
RT @BoggildLab: New paper out today by outstanding @BoggildLab team @ruwandik @PriyankaChalla7 and @rachellau25 on ampho and fluc S…
RT @ruwandik: ❗️New Publication Alert from the @BoggildLab❗️A piece I was thrilled to lead: #Susceptibility testing of #Leishmania spp. aga…
RT @ruwandik: ❗️New Publication Alert from the @BoggildLab❗️A piece I was thrilled to lead: #Susceptibility testing of #Leishmania spp. aga…
RT @BoggildLab: New paper out today by outstanding @BoggildLab team @ruwandik @PriyankaChalla7 and @rachellau25 on ampho and fluc S…
❗️New Publication Alert from the @BoggildLab❗️A piece I was thrilled to lead: #Susceptibility testing of #Leishmania spp. against #amphotericinB and #fluconazole using the Sensititre™ YeastOne™ YO9 platform @PriyankaChalla7 @rachellau25 https://t.co/G3036p
RT @BoggildLab: New paper out today by outstanding @BoggildLab team @ruwandik @PriyankaChalla7 and @rachellau25 on ampho and fluc S…
RT @BoggildLab: New paper out today by outstanding @BoggildLab team @ruwandik @PriyankaChalla7 and @rachellau25 on ampho and fluc S…
New paper out today by outstanding @BoggildLab team @ruwandik @PriyankaChalla7 and @rachellau25 on ampho and fluc Susceptibility testing in Leishmania spp. in BMC ID 🙌👍. MICs>256 for fluc across spp @BioMedCentral https://t.co/Jg8XIJKdLJ